May 8, 2018 / 10:48 PM / 2 months ago

BRIEF-Aclaris Therapeutics Q1 Loss Per Share $0.98

May 8 (Reuters) - Aclaris Therapeutics Inc:

* ACLARIS THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES UPDATE ON CLINICAL AND COMMERCIAL DEVELOPMENTS

* Q1 REVENUE $1.1 MILLION VERSUS I/B/E/S VIEW $1 MILLION

* QTRLY LOSS PER SHARE $0.98 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below